Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 101–150 of 941 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04821622	Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC	active not recruiting	Phase 3	599	PfizerINDUSTRY	27	Sep 4, 2026	clinicaltrials
NCT05139368	Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer(RT-PACE)	active not recruiting	N/A	22	University of UtahOTHER	1	Sep 4, 2026	clinicaltrials